Inovio Pharmaceuticals, Inc. (NASDAQ: INO) saw its stock rise by 7.52% in after-hours trading on Thursday, July 3, 2025, reaching $1.43 after announcing $25M public offering at $1.75 per share.
INOVIO Pharmaceuticals, Inc. (INO) announced the pricing of an underwritten public offering of 14,285,715 shares of its common stock at an exercise price of $1.75 per share. The gross proceeds from the offering by INOVIO Pharmaceuticals, Inc. (INO) are expected to be approximately $25 million. The offering is anticipated to close on or about July 7, 2025.
The stock had closed the regular trading session at $1.33. During the day, INO’s price fluctuated between a low of $1.30 and a high of $1.54, with a total trading volume of 20.27 million shares. The stock opened the session at $1.51 before settling into its daily range.
